DTR03-covtabs Production Final 5/19/04 4:15 PM Page 13
AGE AND GENDER APPENDIX
5 AGE AND GENDERAPPENDIX E X P R E S S S C R I P T S D R U G T R E N D R E P O R T
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 143
AGE AND GENDER APPENDIX Drug Prevalence by Age and Gender
This appendix to the 2003 Drug Trend Report presents the prevalence ofuse by age and gender for the top 25 therapy classes ranked by cost. Thesample of members used to determine prevalence and to create these chartswas the same sample of 2.1 million members whose prescription use wasanalyzed to determine overall trend from 2002 to 2003. These membersbelonged to groups offering a funded benefit that allowed members touse either retail or mail pharmacies. Members belonging to groups withMedicare or Medicaid benefits were excluded.
For the purpose of this appendix, prevalence was defined as the percentageof eligible members who filled at least one prescription in the therapyclass during 2003. Age was determined by the member’s age on the lastday of 2003. Antihyperlipidemics Prevalence of Use by Age and Gender 2003
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 144
AGE AND GENDER APPENDIX Gastrointestinals Antihypertensives Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003 AGE AND GENDER APPENDIX
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
Antidepressants Anti-Rheumatics (NSAIDs) Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
144 express scripts drug trend report 2003
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 146
AGE AND GENDER APPENDIX Antidiabetics Miscellaneous Endocrines Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003 AGE AND GENDER APPENDIX
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
Antiasthmatics Narcotic Analgesics Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
146 express scripts drug trend report 2003
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 148
AGE AND GENDER APPENDIX Anticonvulsants Dermatologicals Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003 AGE AND GENDER APPENDIX
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
Antivirals Antihistamines Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
148 express scripts drug trend report 2003
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 150
AGE AND GENDER APPENDIX Calcium Blockers Oral Contraceptives Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age 2003 AGE AND GENDER APPENDIX
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
Beta Blockers Miscellaneous CNS Agents Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
150 express scripts drug trend report 2003
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 152
AGE AND GENDER APPENDIX Antineoplastics Quinolones Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003 AGE AND GENDER APPENDIX
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
Decongestants Antipsychotics Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
152 express scripts drug trend report 2003
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 154
AGE AND GENDER APPENDIX Migraine Products Macrolides Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age and Gender 2003 AGE AND GENDER APPENDIX
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
Stimulants/Anti-Obesity Estrogens Prevalence of Use by Age and Gender 2003 Prevalence of Use by Age 2003
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
0-4 10-14 20-24 30-34 40-44 50-54 60-64 70-74 80-84
154 express scripts drug trend report 2003
drugtrend-agegen5rev2 5/19/04 4:30 PM Page 156
Notes AGE AND GENDER APPENDIX 156 express scripts drug trend report 2003
Weitere Fragen? Wir hoffen, Ihnen vorerst alle notwendigen Informationen gegeben zu haben. Vor der eigentlichen Operation ergibt sich noch die Gelegenheit zu einem persönlichen Gespräch. Information zur Kataraktoperation Sollten immer noch Fragen oder Unsicherheiten bestehen, die Sie zuvor klären möchten, zögern Sie bitte nicht, mit uns Kontakt aufzunehmen. Sie erreichen uns in
Parasite Consequence if left untreated / Clinical Diagnosis Treatment The majority of infections with A. lumbricoides are asymptomatic, and symptoms are largely restricted to individuals with a high worm load Adult worms do not multiply in the human host, so the number of adult worms per infected person relates to the degree of continued exposure to infectious eggs over time. Unt